Exercise app trial aims to unlock Chemo-Brain relief for cancer survivors

NCT ID NCT06725953

Recruiting now Knowledge-focused Sponsor: University of Oklahoma Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how a 12-week physical activity program, delivered through smartphone apps and a Fitbit, affects brain function in cancer survivors who report 'chemo-brain' (cognitive problems after chemotherapy). Researchers will compare survivors with and without type 2 diabetes to see if diabetes makes chemo-brain worse. The goal is to understand the underlying causes and whether exercise can help.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: physical activity program delivered via smartphone apps and Fitbit
What this could lead to: If successful, this could show that a home-based physical activity program helps improve brain function and reduce inflammation in cancer survivors with chemo-brain, especially those with type 2 diabetes.
What could go wrong: This is a small pilot study with only 38 participants, so results may not apply to everyone. The program relies on self-motivation, and some people may not complete it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER SURVIVORSHIP are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chemotherapy-induced toxicity type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER SURVIVORSHIP CHEMOTHERAPY SIDE EFFECTS

Contacts and locations

Locations

University of Oklahoma Health Sciences
RECRUITING

Oklahoma City, Oklahoma, 73104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.